Evaluation of psychological symptoms among presymptomatic HD gene carriers as measured by selected MMPI scales

Sandra Close Kirkwood, Eric Siemers, Richard J. Viken, M. E. Hodes, P. Michael Conneally, Joe C. Christian, Tatiana Foroud

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Individuals at-risk for Huntington disease (HD), both HD gene carriers and nongene carriers, were recruited to determine whether psychological changes are detectable among clinically presymptomatic individuals who carry the HD allele. Each participant underwent genotyping to determine HD gene carrier status and a clinical assessment that included a quantified neurological examination and an abbreviated Minnesota Multiphasic Personality Inventory (MMPI): the Hypochondriasis, Depression, Psychasthenia, Neuroticism, Cynical Hostility, and Irritability Scales and the Harris Subscales of Depression. The results of the MMPI were evaluated for differences between nongene carriers (NGC) (n=363), presymptomatic gene carriers (PSGC) (n=149), and those with manifest HD (MHD) (n=26). The overall multiple analysis of variance was not significant, indicating that there was no overall difference among the three groups. However, when subscales of the MMPI were examined individually, participants with manifest HD scored higher on the Psychasthenia scale (MHD vs. PSGC, P=0.005; MHD vs. NGC, P=0.03) and the Harris Depression subscale, Brooding (MHD vs. PSGC, P=0.0005; MHD vs. NGC, P=0.003). No significant correlation was found between the number of trinucleotide repeats on the disease-producing allele and any of the MMPI scales for the gene carriers, MHD or PSGC. These results verify the presence of psychological symptoms in the early phases of MHD but not in PSGC. Thus, further study of the behavioral and mood symptoms thought to accompany HD using measures designed specifically to detect depressive symptoms and changes in behavior specific to HD is warranted to delineate the timing of onset of the psychological symptoms.

Original languageEnglish
Pages (from-to)377-382
Number of pages6
JournalJournal of Psychiatric Research
Volume36
Issue number6
DOIs
StatePublished - Nov 2002

Fingerprint

Asymptomatic Diseases
MMPI
Symptom Assessment
Huntington Disease
Psychology
Genes
Depression
Alleles
Hypochondriasis
Trinucleotide Repeats
Behavioral Symptoms
Hostility
Neurologic Examination
Analysis of Variance

Keywords

  • Huntington disease
  • Presymptomatic symptom progression

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)

Cite this

Evaluation of psychological symptoms among presymptomatic HD gene carriers as measured by selected MMPI scales. / Close Kirkwood, Sandra; Siemers, Eric; Viken, Richard J.; Hodes, M. E.; Conneally, P. Michael; Christian, Joe C.; Foroud, Tatiana.

In: Journal of Psychiatric Research, Vol. 36, No. 6, 11.2002, p. 377-382.

Research output: Contribution to journalArticle

Close Kirkwood, Sandra ; Siemers, Eric ; Viken, Richard J. ; Hodes, M. E. ; Conneally, P. Michael ; Christian, Joe C. ; Foroud, Tatiana. / Evaluation of psychological symptoms among presymptomatic HD gene carriers as measured by selected MMPI scales. In: Journal of Psychiatric Research. 2002 ; Vol. 36, No. 6. pp. 377-382.
@article{5da55416bcad42c08ddb526279f4f610,
title = "Evaluation of psychological symptoms among presymptomatic HD gene carriers as measured by selected MMPI scales",
abstract = "Individuals at-risk for Huntington disease (HD), both HD gene carriers and nongene carriers, were recruited to determine whether psychological changes are detectable among clinically presymptomatic individuals who carry the HD allele. Each participant underwent genotyping to determine HD gene carrier status and a clinical assessment that included a quantified neurological examination and an abbreviated Minnesota Multiphasic Personality Inventory (MMPI): the Hypochondriasis, Depression, Psychasthenia, Neuroticism, Cynical Hostility, and Irritability Scales and the Harris Subscales of Depression. The results of the MMPI were evaluated for differences between nongene carriers (NGC) (n=363), presymptomatic gene carriers (PSGC) (n=149), and those with manifest HD (MHD) (n=26). The overall multiple analysis of variance was not significant, indicating that there was no overall difference among the three groups. However, when subscales of the MMPI were examined individually, participants with manifest HD scored higher on the Psychasthenia scale (MHD vs. PSGC, P=0.005; MHD vs. NGC, P=0.03) and the Harris Depression subscale, Brooding (MHD vs. PSGC, P=0.0005; MHD vs. NGC, P=0.003). No significant correlation was found between the number of trinucleotide repeats on the disease-producing allele and any of the MMPI scales for the gene carriers, MHD or PSGC. These results verify the presence of psychological symptoms in the early phases of MHD but not in PSGC. Thus, further study of the behavioral and mood symptoms thought to accompany HD using measures designed specifically to detect depressive symptoms and changes in behavior specific to HD is warranted to delineate the timing of onset of the psychological symptoms.",
keywords = "Huntington disease, Presymptomatic symptom progression",
author = "{Close Kirkwood}, Sandra and Eric Siemers and Viken, {Richard J.} and Hodes, {M. E.} and Conneally, {P. Michael} and Christian, {Joe C.} and Tatiana Foroud",
year = "2002",
month = "11",
doi = "10.1016/S0022-3956(02)00054-7",
language = "English",
volume = "36",
pages = "377--382",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Evaluation of psychological symptoms among presymptomatic HD gene carriers as measured by selected MMPI scales

AU - Close Kirkwood, Sandra

AU - Siemers, Eric

AU - Viken, Richard J.

AU - Hodes, M. E.

AU - Conneally, P. Michael

AU - Christian, Joe C.

AU - Foroud, Tatiana

PY - 2002/11

Y1 - 2002/11

N2 - Individuals at-risk for Huntington disease (HD), both HD gene carriers and nongene carriers, were recruited to determine whether psychological changes are detectable among clinically presymptomatic individuals who carry the HD allele. Each participant underwent genotyping to determine HD gene carrier status and a clinical assessment that included a quantified neurological examination and an abbreviated Minnesota Multiphasic Personality Inventory (MMPI): the Hypochondriasis, Depression, Psychasthenia, Neuroticism, Cynical Hostility, and Irritability Scales and the Harris Subscales of Depression. The results of the MMPI were evaluated for differences between nongene carriers (NGC) (n=363), presymptomatic gene carriers (PSGC) (n=149), and those with manifest HD (MHD) (n=26). The overall multiple analysis of variance was not significant, indicating that there was no overall difference among the three groups. However, when subscales of the MMPI were examined individually, participants with manifest HD scored higher on the Psychasthenia scale (MHD vs. PSGC, P=0.005; MHD vs. NGC, P=0.03) and the Harris Depression subscale, Brooding (MHD vs. PSGC, P=0.0005; MHD vs. NGC, P=0.003). No significant correlation was found between the number of trinucleotide repeats on the disease-producing allele and any of the MMPI scales for the gene carriers, MHD or PSGC. These results verify the presence of psychological symptoms in the early phases of MHD but not in PSGC. Thus, further study of the behavioral and mood symptoms thought to accompany HD using measures designed specifically to detect depressive symptoms and changes in behavior specific to HD is warranted to delineate the timing of onset of the psychological symptoms.

AB - Individuals at-risk for Huntington disease (HD), both HD gene carriers and nongene carriers, were recruited to determine whether psychological changes are detectable among clinically presymptomatic individuals who carry the HD allele. Each participant underwent genotyping to determine HD gene carrier status and a clinical assessment that included a quantified neurological examination and an abbreviated Minnesota Multiphasic Personality Inventory (MMPI): the Hypochondriasis, Depression, Psychasthenia, Neuroticism, Cynical Hostility, and Irritability Scales and the Harris Subscales of Depression. The results of the MMPI were evaluated for differences between nongene carriers (NGC) (n=363), presymptomatic gene carriers (PSGC) (n=149), and those with manifest HD (MHD) (n=26). The overall multiple analysis of variance was not significant, indicating that there was no overall difference among the three groups. However, when subscales of the MMPI were examined individually, participants with manifest HD scored higher on the Psychasthenia scale (MHD vs. PSGC, P=0.005; MHD vs. NGC, P=0.03) and the Harris Depression subscale, Brooding (MHD vs. PSGC, P=0.0005; MHD vs. NGC, P=0.003). No significant correlation was found between the number of trinucleotide repeats on the disease-producing allele and any of the MMPI scales for the gene carriers, MHD or PSGC. These results verify the presence of psychological symptoms in the early phases of MHD but not in PSGC. Thus, further study of the behavioral and mood symptoms thought to accompany HD using measures designed specifically to detect depressive symptoms and changes in behavior specific to HD is warranted to delineate the timing of onset of the psychological symptoms.

KW - Huntington disease

KW - Presymptomatic symptom progression

UR - http://www.scopus.com/inward/record.url?scp=0036829059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036829059&partnerID=8YFLogxK

U2 - 10.1016/S0022-3956(02)00054-7

DO - 10.1016/S0022-3956(02)00054-7

M3 - Article

VL - 36

SP - 377

EP - 382

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

IS - 6

ER -